By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Carbapenems / beta-lactamase inhibitors > Vabomere > Vabomere Side Effects
Carbapenems / beta-lactamase inhibitors

Vabomere Side Effects

Note: This document contains side effect information about meropenem / vaborbactam. Some dosage forms listed on this page may not apply to the brand name Vabomere.

Applies to meropenem / vaborbactam: intravenous powder for solution.

Serious side effects of Vabomere

Along with its needed effects, meropenem/vaborbactam may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking meropenem / vaborbactam:

Less common

  • Bluish color
  • changes in skin color
  • decreased urine
  • diarrhea
  • dry mouth
  • increased thirst
  • irregular heartbeat
  • loss of appetite
  • mood changes
  • muscle pain or cramps
  • nausea
  • numbness or tingling in the hands, feet, or lips
  • seizures
  • swelling of the foot or leg
  • unusual tiredness or weakness
  • vomiting

Rare

  • Anxiety
  • black, tarry stools
  • bloody or cloudy urine
  • blurred vision
  • body aches or pain
  • chest discomfort
  • chest pain
  • chills
  • cold sweats
  • confusion
  • cool, pale skin
  • cough
  • depression
  • difficulty breathing
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • dryness or soreness of the throat
  • fast heartbeat
  • fever
  • flushed, dry skin
  • fruit-like breath odor
  • headache
  • hoarseness
  • increased hunger
  • increased urination
  • itching of the vagina or genitals
  • loss of consciousness
  • nervousness
  • nightmares
  • pain in the lower back or side
  • pain, redness, or swelling in the arm or leg
  • painful or difficult urination
  • runny nose
  • seeing, hearing, or feeling things that are not there
  • shakiness
  • slurred speech
  • sore mouth, throat, or tongue
  • sores, ulcers, or white spots on the lips or in the mouth
  • stomach pain
  • sweating
  • tender, swollen glands in the neck
  • thick, white vaginal discharge with mild or no odor
  • trouble in swallowing
  • unexplained weight loss
  • unusual bleeding or bruising
  • voice changes
  • weakness or heaviness of the legs

Other side effects of Vabomere

Some side effects of meropenem / vaborbactam may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • decreased appetite

For Healthcare Professionals

Applies to meropenem / vaborbactam: intravenous powder for injection.

General

The most common side effects were headache, phlebitis/infusion site reactions, infusion site phlebitis, diarrhea, and nausea. This drug was discontinued due to a side effect in 2.9% (8/272) of patients (compared to 5.1% [14/273] of patients using piperacillin-tazobactam); therapy was discontinued most commonly due to hypersensitivity and infusion-related reactions. Death occurred in 0.7% of patients using this drug and in 0.7% of patients using piperacillin-tazobactam.[Ref]

Nervous system

Common (1% to 10%): Headache

Uncommon (0.1% to 1%): Dizziness, tremor, paresthesia, lethargy

Meropenem:

-Rare (0.01% to 0.1%): Convulsions[Ref]

Local

Common (1% to 10%): Phlebitis/infusion site reactions (included infusion/injection site phlebitis, infusion site thrombosis, infusion site erythema), infusion site phlebitis

Uncommon (0.1% to 1%): Infusion site erythema, injection site phlebitis, infusion site thrombosis, infusion related reaction[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, nausea, vomiting

Uncommon (0.1% to 1%): Abdominal distension, Clostridioides difficile colitis, oral candidiasis

Frequency not reported: C difficile-associated diarrhea

Meropenem:

-Uncommon (0.1% to 1%): Abdominal pain[Ref]

Hypersensitivity

Common (1% to 10%): Hypersensitivity (included hypersensitivity, drug hypersensitivity, anaphylactic reaction, rash, urticaria, bronchospasm)

Uncommon (0.1% to 1%): Anaphylactic reaction[Ref]

Hepatic

Common (1% to 10%): Increased ALT, increased AST

Meropenem:

-Uncommon (0.1% to 1%): Increased blood bilirubin

-Frequency not reported: Jaundice[Ref]

Other

Common (1% to 10%): Pyrexia

Uncommon (0.1% to 1%): Chest discomfort

Meropenem:

-Common (1% to 10%): Increased blood alkaline phosphatase, increased blood LDH

-Uncommon (0.1% to 1%): Pain[Ref]

Metabolic

Common (1% to 10%): Hypokalemia, hypoglycemia

Uncommon (0.1% to 1%): Decreased appetite, hyperkalemia, hyperglycemia[Ref]

Cardiovascular

Common (1% to 10%): Hypotension

Uncommon (0.1% to 1%): Vascular pain

Frequency not reported: Deep vein thrombosis[Ref]

Dermatologic

Uncommon (0.1% to 1%): Rash, urticaria

Meropenem:

-Uncommon (0.1% to 1%): Pruritus

-Postmarketing reports: Toxic epidermal necrolysis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, erythema multiforme, angioedema[Ref]

Hematologic

Uncommon (0.1% to 1%): Leukopenia

Meropenem:

-Common (1% to 10%): Thrombocytosis/thrombocythemia

-Uncommon (0.1% to 1%): Neutropenia, eosinophilia, thrombocytopenia

-Frequency not reported: Decreased blood thromboplastin, decreased prothrombin time

-Postmarketing reports: Agranulocytosis, hemolytic anemia, positive direct and indirect Coombs test[Ref]

Musculoskeletal

Uncommon (0.1% to 1%): Increased blood creatine phosphokinase[Ref]

Psychiatric

Uncommon (0.1% to 1%): Hallucination, insomnia[Ref]

Renal

Uncommon (0.1% to 1%): Renal impairment

Frequency not reported: Azotemia

Meropenem:

-Uncommon (0.1% to 1%): Increased blood creatinine, increased blood urea[Ref]

Respiratory

Uncommon (0.1% to 1%): Bronchospasm

Frequency not reported: Pharyngitis[Ref]

Genitourinary

Uncommon (0.1% to 1%): Vulvovaginal candidiasis, incontinence[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by